Compile Data Set for Download or QSAR
Found 5 Enz. Inhib. hit(s) with all data for assayid = 1 entry = 7712
TargetBeta-lactamase(Pseudomonas aeruginosa (PAO1))
Meiji Seika Pharma Co., Ltd.

US Patent
LigandPNGBDBM212440(US8772490, H)copy SMILEScopy InChI
Affinity DataIC50: 650nMpH: 7.0 T: 2°CAssay Description:For the measurement of β-lactamase inhibitory activity, 100 uM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% DMSO, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NK3CWQUS Patent
TargetBeta-lactamase(Pseudomonas aeruginosa (PAO1))
Meiji Seika Pharma Co., Ltd.

US Patent
LigandPNGBDBM159600(US8772490, Example 23 | US9035062, 23)copy SMILEScopy InChI
Affinity DataIC50: 650nMpH: 7.0 T: 2°CAssay Description:For the measurement of β-lactamase inhibitory activity, 100 uM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% DMSO, ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NK3CWQUS Patent
TargetBeta-lactamase(Pseudomonas aeruginosa (PAO1))
Meiji Seika Pharma Co., Ltd.

US Patent
LigandPNGBDBM212441(US8772490, TAZ)copy SMILEScopy InChI
Affinity DataIC50: 950nMpH: 7.0 T: 2°CAssay Description:For the measurement of β-lactamase inhibitory activity, 100 uM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% DMSO, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NK3CWQUS Patent
TargetBeta-lactamase(Pseudomonas aeruginosa (PAO1))
Meiji Seika Pharma Co., Ltd.

US Patent
LigandPNGBDBM159601(US8772490, Example 24 | US9035062, 24)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMpH: 7.0 T: 2°CAssay Description:For the measurement of β-lactamase inhibitory activity, 100 uM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% DMSO, ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NK3CWQUS Patent
TargetBeta-lactamase(Pseudomonas aeruginosa (PAO1))
Meiji Seika Pharma Co., Ltd.

US Patent
LigandPNGBDBM159601(US8772490, Example 24 | US9035062, 24)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMpH: 7.0 T: 2°CAssay Description:For the measurement of β-lactamase inhibitory activity, 100 uM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% DMSO, ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NK3CWQUS Patent